by John Conrad | Jun 3, 2020 | Community News
Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies Pfizer Inc. (NYSE: PFE) announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to...
by John Conrad | Apr 23, 2020 | Community News, COVID
As the COVID-19 crisis continues to unfold, Takeda’s Patient Assistance Response team is working around the clock to help ensure that the people who need our medicines and treatments can continue to access them safely and without interruption. Consistent with our...
by John Conrad | Apr 6, 2020 | Community News, COVID
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and...
by John Conrad | Mar 31, 2020 | Community News, COVID
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
by John Conrad | Mar 30, 2020 | Community News
The AIM-HI Accelerator Fund, a venture philanthropy organization created in 2019 with support from the National Foundation for Cancer Research, will conduct its 2020 Women’s Venture Competition later this year in Boston—originally scheduled for May 20 but potentially...
by John Conrad | Mar 30, 2020 | Community News, COVID
Medtronic is publicly sharing the designs for one of its ventilator models to help people across the world to devise options for rapid ventilator manufacturing. The move is designed to help doctors and patients combat the impact of Covid-19. The Puritan Bennet 560 has...
